Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03323567Phase 1Completed
Phase 1, randomised, single-blind trial of MD-MUSCLE in temporomandibular joint disorders (TMD) (3 arms), sponsored by Medical University of Silesia. Primary endpoint: Reduction of sEMG activity of masseter muscles at 14 days. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03323567.